CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-21 | Rodriguez Susan Chief Commercial Officer | Sale | −5,586 | $3.00 | $17K | 355,131 |
| 2023-02-21 | Williams Laura A Chief Medical Officer | Sale | −3,187 | $3.00 | $10K | 319,013 |
| 2023-02-21 | Blanks Robert | Sale | −3,394 | $3.00 | $10K | 268,969 |
| 2023-02-21 | GRAMMER ELIZABETH A | Sale | −2,914 | $3.00 | $9K | 329,954 |
| 2023-02-21 | RAAB MICHAEL President & CEO | Sale | −13,449 | $3.00 | $40K | 896,012 |
| 2023-02-21 | Felsch Robert Ora | Sale | −3,214 | $3.00 | $10K | 114,204 |
| 2023-02-21 | Renz Justin A Chief Financial Officer | Sale | −3,439 | $3.00 | $10K | 336,606 |
| 2023-02-21 | Rosenbaum David P. Chief Development Officer | Sale | −3,394 | $3.00 | $10K | 375,600 |
| 2023-02-21 | Rosenbaum David P. Chief Development Officer | Sale | −1,114 | $3.00 | $3K | 113,096 |
| 2023-01-05 | Rosenbaum David P. Chief Development Officer | Grant or award | +78,000 | 378,994 | ||
| 2023-01-05 | Rosenbaum David P. Chief Development Officer | Grant or award | +25,325 | 114,210 | ||
| 2023-01-05 | Rosenbaum David P. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +351,000 | 351,000 | ||
| 2023-01-05 | Rosenbaum David P. Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +116,250 | 116,250 | ||
| 2023-01-05 | Felsch Robert Ora | Grant or award | +26,000 | 117,418 | ||
| 2023-01-05 | Felsch Robert Ora | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2023-01-05 | Blanks Robert | Grant or award | +78,000 | 272,363 | ||
| 2023-01-05 | Blanks Robert | Grant or award · Stock Option (Right to Buy) | +351,000 | 351,000 | ||
| 2023-01-05 | GRAMMER ELIZABETH A | Grant or award | +78,000 | 332,868 | ||
| 2023-01-05 | GRAMMER ELIZABETH A | Grant or award · Stock Option (Right to Buy) | +351,000 | 351,000 | ||
| 2023-01-05 | Renz Justin A Chief Financial Officer | Grant or award | +78,000 | 340,045 |
Page 21 of 38 · 756 trades